We identified variable promoter activities of DHS sites 6 and 7 among medulloblastoma cell lines (Fig. 3C), indicative of a role for tumor genetic background (independent of OTX2 status) in affecting proximal regulatory element utilization in this tumor. The gene discussed is OTX2; the disease is neoplasm.